Zinc selenite

Skin sensitisation

Administrative data

Endpoint:

skin sensitisation: in vivo (LLNA)

Type of information:

migrated information: read-across from supporting substance (structural analogue or surrogate)

Adequacy of study:

key study

Study period:

2010-03-18 to 2010-04-29

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

other: Read-across from a GLP guideline study reliable without restrictions, RL1.

Cross-reference

Reason / purpose for cross-reference:

reference to same study

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2010

Report date:

2010

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)

Version / remarks:

, 20002-04-24

Deviations:

yes

Remarks:

modified OECD 429 ,method according to Ehlings et al. 2005

Principles of method if other than guideline:

The test was performed in accordance with the method according to Ehling et al (2005): An European inter-laboratory validation of alternative endpoints of the murine local lymph node assay: first round, Toxicology 212 (2005) 60-68 and Ehling et al (2005): An European inter-laboratory validation of alternative endpoints of the murine local lymph node assay: 2nd round, Toxicology 212 (2005) 69-79.

Threshold values of the stimulation indices of lymph node cell count and ear weight were calculated by dividing the average values per group of the test item treated animals by the vehicle treated ones. Values above 1.4 (cell count) or 1.1 (ear weight) are considered positive
(these values were fixed empirically during the inter-laboratory validation of this method). In addition, the lymph node weights were determined for concentration related properties.

GLP compliance:

yes (incl. QA statement)

Remarks:

signed 2009-11-12

Type of study:

mouse local lymph node assay (LLNA)

Test material

Test material information

Constituent 1

Reference substance name:

Zinc selenite

EC Number:

237-048-9

EC Name:

Zinc selenite

Cas Number:

13597-46-1

Molecular formula:

H2O3Se.Zn

IUPAC Name:

zinc(2+) selenite

Details on test material:

- Name of test material (as cited in study report): zinc selenite
- Chemical name: Zinc selenite
- Substance type: technical product
- Physical state: solid, white powder
- Storage condition of test material: At room temperature, in tightly closed original container, well-ventilated, kept away from water and metals which are attacked by an alkaline medium.

In vivo test system

Test animals

Species:

mouse

Strain:

NMRI

Sex:

female

Details on test animals and environmental conditions:

TEST ANIMALS
- Source: Charles River Laboratories, Research Models and Services, Germany GmbH, Sandhofer Weg 7, 97633 Sulzfeld, Germany
- Age at study initiation: approx. 9 weeks
- Weight at study initiation: 20 - 26 g
- Housing: The animals were kept singly in MAKROLON cages (type III) with a basal surface of approx. 39 cm x 23 cm and a height of approx. 15 cm; Granulated textured wood Granulat A2, J. Brandenburg, 49424 Goldenstedt, Germany) was used as bedding material for the cages.
- Diet (ad libitum): Commercial diet ssniff® R/M-H V1534 served as food (ssniff Spezialdiäten GmbH, 59494 Soest, Germany
- Water (ad libitum): tap water
- Acclimation period: At least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature: 22°C ± 3°C (maximum range)
- Relative humidity: 55% ± 15% (maximum range)
- Air changes: 12 - 18 times per hour.
- Photoperiod (hrs dark / hrs light): 12 / 12
No further information on the test animals was stated.

Study design: in vivo (LLNA)

Vehicle:

other: acetone/olive oil (3 + 1, v/v)

Concentration:

0.25 %, 0.5 %, 1.0 %, and 2.5 % of zinc selenite (w/w)

No. of animals per dose:

6 female mice

Details on study design:

RANGE FINDING TESTS:
A preliminary experiment was carried out in 21 animals to examine the systemic toxicity, the irritating potential and handling/application of the test item in order to select the appropriate concentrations. Six concentrations of 1% (3 animals), 2.5% (3 animals), 5% (3 animals), 10% (4 animals), 25% (4 animals) and 50% (4 animals) of zinc selenite in acetone/olive oil (3+1 v/v), w/w, were examined.
Results:
Concentrations of 5% or 10% cause mortality in one of 3 or 1 of 4 animals, respectively. All four of 4 animals treated with concentrations of 25% or 50%, respectively, died prematurely. No pronounced irritating properties were observed in this preliminary experiment at concentrations of 1.0 % or 2.5 %, and no difference in ear weight and ear thickness were noted.
Hence, for the main study concentrations of 0.25%, 0.5%, 1.0% or 2.5% were used.

MAIN STUDY
The test item was suspended in a mixture of acetone (Batch no. 90980, SIGMA ALDRICH Chemie GmbH, 82024 Taufkirchen, Germany) / olive oil (Batch nos. 4535401 and 4602602, Henry Lamotte GmbH, 28197 Bremen, Germany) (3 + 1), v/v).
The test item suspension was administered to the dorsum of both animal's ears at an application volume of 25 µL/ear.
The concentrations used in the main study were chosen based on the preliminary dose range finding.

The experimental schedule of the assay was as follows:
Day 1:
The weight of each animal was individually identified and recorded. In addition, ear swelling measurements were carried out at the helical edge of both ears using an Oditest micrometer.
Open application of 25 µL of the appropriate dilution of the test item, the vehicle alone or the positive control (as appropriate) were administered to the dorsum of each ear.
Days 2 and 3:
The application procedure carried out on day 1 was repeated.
Day 4 (24 hours after the last application the animals were sacrificed under ether anaesthesia by cutting the aorta abdominalis):
Ear swelling measurements (immediately before sacrificing the mice) were carried out at the helical edge of both ears using an Oditest micrometer.
Punch biopsies of 8 mm in diameter of the apical area of both ears were prepared and immediately weighed on an analytical balance.
Lateral pairs of auricular lymph nodes draining the ear tissue were excised, carefully separated from remaining fatty tissue and weighed on an analytical balance immediately following preparation. The lymph nodes were then stored on ice in PBS/0.5% BSA and subjected to the preparation of single cell suspensions by mechanical tissue disaggregation. The cells were counted automatically in a cell counter.

OBSERVATIONS:
The following observations were made during the course of the study:
- Clinical signs: Animals were observed once daily for any clinical signs of local systemic irritation at the application site or of systemic toxicity. Observations were recorded for each individual animal. Cageside observations included skin/fur, eyes, mucous membranes, respiratory and circulatory systems, somatomotor activity and behaviour patterns. The onset, intensity and duration of any signs observed were recorded.
In addition, animals were checked regularly throughout the working day from 7:30 a.m. to 4:30 p.m. On Saturdays and Sundays animals were checked regularly from 8:00 a.m. to 12:00 noon with a final check performed at approximately 4:00 p.m., if applicable.
- Body weight: The weight of each mouse was recorded at the time of allocation of animals to groups (test day 1) and at the time of necropsy (test day 4).

ANALYSIS OF RESULTS:
The so-called stimulation (or LLN-) indices to determine the sensitising potential were calculated by dividing the average absolute lymph node weight or lymph node cell counts per group of the test item treated animals by the vehicle treated ones.
Thus, in case of no stimulating effect the index for the lymph node cell count is always below 1.4 (cut-off value). An index above 1.4 is considered positive.
For lymph node weight significance at p≤ 0.01 is considered positive (U-test according to MANN and WHITNEY). A possible concentration-response-relationship for the lymph node weight in order to determine a possible sensitising potential was examined by linear regression analysis employing PEARSON's correlation coefficient. Outliers would have been determined according to the NALIMOV test.
In addition, the acute inflammatory skin reaction (irritating potential) was measured by ear weight determination of circular biopsies of the ears and ear thickness measurements on test day 1 and test day 4 to identify skin irritation properties of the test item employing the U-test according to MANN and WHITNEY by comparing the test groups to the vehicle control.
The stimulation indices were calculated by dividing the average ear weight and average ear thickness on test day 4 per group of the test item treated animals by the vehicle treated ones. The cut-off threshold value for ear weight was set at 1.1.
No further information on the study design was stated.

Positive control substance(s):

hexyl cinnamic aldehyde (CAS No 101-86-0)

Statistics:

Please refer to "Details on study design (LLNA)"

Results and discussion

Positive control results:

The positive control group caused the expected increases in lymph node cell count and lymph node weight (statistically significant at p ≤ 0.01). The values for the stimulation index of lymph node cell count and lymph node weight were 1.66 and 1.67, respectively. Therefore, the study could be regarded as valid.

In vivo (LLNA)

Results

Results 1

Parameter:

SI

Remarks:

cell count

Value:

0.623

Test group / Remarks:

4 animals, 0.25%

Remarks on result:

other: see Remark

Remarks:

Threshold values of the stimulation indices of lymph node cell count and ear weight were calculated by dividing the average values per group of the test item treated animals by the vehicle treated ones. Values above 1.4 (cell count) or 1.1 (ear weight) are considered positive (these values were fixed empirically during the inter-laboratory validation of this method). 0.25 % w/w: SI: 0.623 (cell count); SI: 0.753 (lymph node weight) 0.5 % w/w: SI: 0.861 (cell count); SI: 0.928 (lymph node weight) 1.0 % w/w: SI: 0.966 (cell count); SI: 1.052 (lymph node weight) 2.5 % w/w: SI: 0.408 (cell count); SI: 0.588 (lymph node weight) Please refer to "Attached background material" for the raw data

Results 2

Parameter:

other: disintegrations per minute (DPM)

Remarks on result:

other: Not applicable

Results 3

Parameter:

SI

Remarks:

cell count

Value:

0.861

Test group / Remarks:

4 animals, 0.5%

Remarks on result:

other: see remarks

Remarks:

Threshold values of the stimulation indices of lymph node cell count and ear weight were calculated by dividing the average values per group of the test item treated animals by the vehicle treated ones. Values above 1.4 (cell count) or 1.1 (ear weight) are considered positive (these values were fixed empirically during the inter-laboratory validation of this method). 0.25 % w/w: SI: 0.623 (cell count); SI: 0.753 (lymph node weight) 0.5 % w/w: SI: 0.861 (cell count); SI: 0.928 (lymph node weight) 1.0 % w/w: SI: 0.966 (cell count); SI: 1.052 (lymph node weight) 2.5 % w/w: SI: 0.408 (cell count); SI: 0.588 (lymph node weight) Please refer to "Attached background material" for the raw data

Results 4

Parameter:

SI

Remarks:

cell count

Value:

0.966

Test group / Remarks:

4 animals, 1%

Remarks on result:

other: see remarks

Remarks:

Threshold values of the stimulation indices of lymph node cell count and ear weight were calculated by dividing the average values per group of the test item treated animals by the vehicle treated ones. Values above 1.4 (cell count) or 1.1 (ear weight) are considered positive (these values were fixed empirically during the inter-laboratory validation of this method). 0.25 % w/w: SI: 0.623 (cell count); SI: 0.753 (lymph node weight) 0.5 % w/w: SI: 0.861 (cell count); SI: 0.928 (lymph node weight) 1.0 % w/w: SI: 0.966 (cell count); SI: 1.052 (lymph node weight) 2.5 % w/w: SI: 0.408 (cell count); SI: 0.588 (lymph node weight) Please refer to "Attached background material" for the raw data

Results 5

Parameter:

SI

Remarks:

cell count

Value:

0.408

Test group / Remarks:

4 animals, 2.5%

Remarks on result:

other: see remarks

Remarks:

Threshold values of the stimulation indices of lymph node cell count and ear weight were calculated by dividing the average values per group of the test item treated animals by the vehicle treated ones. Values above 1.4 (cell count) or 1.1 (ear weight) are considered positive (these values were fixed empirically during the inter-laboratory validation of this method). 0.25 % w/w: SI: 0.623 (cell count); SI: 0.753 (lymph node weight) 0.5 % w/w: SI: 0.861 (cell count); SI: 0.928 (lymph node weight) 1.0 % w/w: SI: 0.966 (cell count); SI: 1.052 (lymph node weight) 2.5 % w/w: SI: 0.408 (cell count); SI: 0.588 (lymph node weight) Please refer to "Attached background material" for the raw data

Any other information on results incl. tables

Treatment with zinc selenite at concentrations of 0.25%, 0.5%, 1.0% and 2.5% did not reveal statistical significantly increased values for lymph node cell count. The stimulation indices of the lymph node cell count did not exceed the threshold level of 1.4. Hence, the test item is classified as not sensitising.

The threshold level for the ear weight of 1.1 was not exceeded and the lymph node weights were not increased in a dose-related way, i.e. no irritating properties were noted.

No signs of local or systemic intolerance were recorded.

The animal body weight was not affected by the treatment with concentrations up to 1.0% Zinc selenite. Treatment with a concentration of 2.5% revealed a reduction of body weight from the initial value (day 1) by 16.7% on test day 4. Lymph node cell count, ear weights and lymph node weights were reduced at all tested concentrations. These findings are probably caused by the toxic properties of the test item.

Applicant's summary and conclusion

Interpretation of results:

not sensitising

Remarks:

Migrated information Criteria used for interpretation of results: other: CLP; EU GHS (Regulation (EC) No 1272/2008)

Conclusions:

Under the present test conditions, zinc selenite at concentrations of 0.25 %, 0.5 %, 1.0 % and 2.5 % (w/w) in acetone/olive oil (3 +1, v/v) did not reveal any sensitising properties in the local lymph node assay.
According to the criteria specified by Regulation (EC) No.: 1272/2008. and subsequent regulations, the test item requires no classification as skin sensitiser.